These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3566254)

  • 21. Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
    Jones RN; Salazar JC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1997 Dec; 29(4):265-72. PubMed ID: 9458984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial susceptibility of Capnocytophaga.
    Forlenza SW; Newman MG; Horikoshi AL; Blachman U
    Antimicrob Agents Chemother; 1981 Jan; 19(1):144-6. PubMed ID: 7247353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
    Williams-Bouyer N; Hernandez A; Reisner BS
    J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A series of infections due to Capnocytophaga spp in immunosuppressed and immunocompetent patients.
    Bonatti H; Rossboth DW; Nachbaur D; Fille M; Aspöck C; Hend I; Hourmont K; White L; Malnick H; Allerberger FJ
    Clin Microbiol Infect; 2003 May; 9(5):380-7. PubMed ID: 12848750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of antibiotics against resistant Pseudomonas aeruginosa.
    Fujita J; Negayama K; Takigawa K; Yamagishi Y; Kubo A; Yamaji Y; Takahara J
    J Antimicrob Chemother; 1992 May; 29(5):539-46. PubMed ID: 1365010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Gruninger RP; Nelson SM; Obaid SR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):477-8. PubMed ID: 6303215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of 100 blood isolates of Pseudomonas aeruginosa to 19 antipseudomonal antibiotics: old and new.
    Korvick J; Yu VL; Hilf M
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):107-11. PubMed ID: 3115670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capnocytophaga spp. involvement in bone infections: a review.
    Piau C; Arvieux C; Bonnaure-Mallet M; Jolivet-Gougeon A
    Int J Antimicrob Agents; 2013 Jun; 41(6):509-15. PubMed ID: 23642766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.
    Neu HC; Saha G; Chin NX
    Diagn Microbiol Infect Dis; 1989; 12(3):283-5. PubMed ID: 2791491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.
    Charteris WP; Kelly PM; Morelli L; Collins JK
    Lett Appl Microbiol; 1998 May; 26(5):333-7. PubMed ID: 9674160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cfxA expression in oral clinical Capnocytophaga isolates.
    Tamanai-Shacoori Z; Monfort C; Oliviero N; Gautier P; Bonnaure-Mallet M; Jolivet-Gougeon A
    Anaerobe; 2015 Oct; 35(Pt B):68-71. PubMed ID: 26204794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of clindamycin on neutrophil killing of gram-negative periodontal bacteria.
    Baker PJ; Wilson ME
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1521-7. PubMed ID: 3056238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capnocytophaga bacteremia: clinical features of patients and antimicrobial susceptibility of isolates.
    Lin RD; Hsueh PR; Chang SC; Luh KT
    J Formos Med Assoc; 1998 Jan; 97(1):44-8. PubMed ID: 9481064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capnocytophaga in the dental plaque of immunocompromised children with cancer.
    Sixou JL; Aubry-Leuliette A; De Medeiros-Battista O; Lejeune S; Jolivet-Gougeon A; Solhi-Pinsard H; Gandemer V; Barbosa-Rogier M; Bonnaure-Mallet M
    Int J Paediatr Dent; 2006 Mar; 16(2):75-80. PubMed ID: 16430520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lactic acid production by oral Streptococcus mitis inhibits the growth of oral Capnocytophaga.
    Mashimo PA; Yamamoto Y; Nakamura M; Reynolds HS; Genco RJ
    J Periodontol; 1985 Sep; 56(9):548-52. PubMed ID: 3861843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.